ANEB
Anebulo Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.36
−8.05%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-2.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 7, 2025 | Lawler Joseph F. · director, 10 percent owner: | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | Lawler Joseph F. · director, 10 percent owner: | A-Award | 13,236 | $1.02 |
| Apr 7, 2025 | SHAH BIMAL R. · director | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | SHAH BIMAL R. · director | A-Award | 6,618 | $1.02 |
| Apr 7, 2025 | Cundy Kenneth C · officer: Chief Scientific Officer | A-Award | 115,037 | $1.02 |
| Apr 7, 2025 | Aryeh Jason · director | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | Aryeh Jason · director | A-Award | 4,964 | $1.02 |
| Apr 7, 2025 | Cunningham, Richard Anthony · director, officer: Chief Executive Officer | A-Award | 316,352 | $1.02 |
| Apr 7, 2025 | Lin Kenneth · director | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | Lin Kenneth · director | A-Award | 4,964 | $1.02 |
| Apr 7, 2025 | English Aron R. · director, 10 percent owner: | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | English Aron R. · director, 10 percent owner: | A-Award | 2,647 | $1.02 |
| Apr 7, 2025 | Calloway Nathaniel · director | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | Kupchyk Areta · director | A-Award | 25,000 | $1.02 |
| Apr 7, 2025 | Calloway Nathaniel · director | A-Award | 3,309 | $1.02 |
| Apr 7, 2025 | Kupchyk Areta · director | A-Award | 2,647 | $1.02 |
| Dec 26, 2024 | English Aron R. · director, 10 percent owner: | Purchase | 10,101,010 | $0.99 |
| Dec 10, 2024 | Cunningham, Richard Anthony · director, officer: Chief Executive Officer | A-Award | 254,433 | $1.56 |
| Jun 17, 2024 | Lin Kenneth · director | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | Lin Kenneth · director | A-Award | 2,482 | $2.10 |
| Jun 17, 2024 | Calloway Nathaniel · director | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | Calloway Nathaniel · director | A-Award | 1,655 | $2.10 |
| Jun 17, 2024 | Kupchyk Areta · director | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | Kupchyk Areta · director | A-Award | 1,324 | $2.10 |
| Jun 17, 2024 | Lawler Joseph F. · director | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | Lawler Joseph F. · director | A-Award | 6,618 | $2.10 |
| Jun 17, 2024 | English Aron R. · director, 10 percent owner: | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | English Aron R. · director, 10 percent owner: | A-Award | 1,324 | $2.10 |
| Jun 17, 2024 | SHAH BIMAL R. · director | A-Award | 41,667 | $2.10 |
| Jun 17, 2024 | SHAH BIMAL R. · director | A-Award | 3,309 | $2.10 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 7, 2025